Koninklijke Philips (PHG) Long-Term Debt Repayments (2009 - 2026)
Koninklijke Philips (PHG) posted quarterly Long-Term Debt Repayments of -$991.5 million for Q2 2026, down 261.95% year-over-year from $612.2 million in Q2 2025, and down 1439.8% quarter-over-quarter from -$64.4 million in Q1 2026.
Koninklijke Philips (PHG) Long-Term Debt Repayments (2009 - 2026) Analysis & Trends
Koninklijke Philips' Long-Term Debt Repayments history runs 18 years deep, the most recent figure standing at -$991.5 million for Q2 2026.
- In Q2 2026, Long-Term Debt Repayments fell 261.95% year-over-year to -$991.5 million; the TTM figure through Jun 2026 stood at -$2.1 billion (down 36.1% YoY), while the FY2024 annual figure was -$815.3 million, down 0.5% from the prior year.
- Long-Term Debt Repayments for Q2 2026 stood at -$991.5 million, down from -$64.4 million in the prior quarter.
- The five-year high for Long-Term Debt Repayments was -$64.1 million in Q1 2024, with the low at -$1.5 billion in Q4 2022.
- The 5-year median for Long-Term Debt Repayments is -$370.7 million (2024), against an average of -$551.4 million.
- The sharpest annual moves came in 2022 and 2023: Long-Term Debt Repayments plunged 714.56% in 2022, then jumped 89.74% in 2023.
- Koninklijke Philips' Long-Term Debt Repayments stood at -$1.5 billion in 2022, then jumped by 45.98% to -$811.3 million in 2023, then declined by 0.5% to -$815.3 million in 2024, then advanced by 13.05% to -$708.9 million in 2025, then plunged by 39.86% to -$991.5 million in 2026.
- Business Quant data shows PHG's Long-Term Debt Repayments at -$991.5 million in Q2 2026, -$64.4 million in Q1 2026, and -$708.9 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.24 Bn | 193.64 Bn | 7.27 Bn | 1.41 Bn |
| 2 | Stryker | 128.63 Bn | 125.15 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.19 Bn | 109.97 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.51 Bn | 72.97 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.11 Bn | 47.85 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 34.01 Bn | 31.90 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.40 Bn | 23.08 Bn | 4.55 Bn | -927.56 Mn |
| 9 | Steris | 23.14 Bn | 22.65 Bn | 684.20 Mn | - |
| 10 | Zimmer Biomet Holdings | 19.32 Bn | 18.91 Bn | 1.54 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -991.49 Mn |
| Jun 30, 2026 | -991.49 Mn |
| Mar 31, 2026 | -64.39 Mn |
| Mar 31, 2026 | -64.39 Mn |
| Dec 31, 2025 | -708.90 Mn |
| Dec 31, 2025 | -708.90 Mn |
| Sep 30, 2025 | -346.04 Mn |
| Sep 30, 2025 | -346.04 Mn |
| Jun 30, 2025 | -273.93 Mn |
| Jun 30, 2025 | -273.93 Mn |
| Mar 31, 2025 | -66.27 Mn |
| Mar 31, 2025 | -66.27 Mn |
| Dec 31, 2024 | -815.34 Mn |
| Dec 31, 2024 | -815.34 Mn |
| Sep 30, 2024 | -395.36 Mn |
| Sep 30, 2024 | -395.36 Mn |
| Jun 30, 2024 | -113.07 Mn |
| Jun 30, 2024 | -113.07 Mn |
| Mar 31, 2024 | -64.10 Mn |
| Mar 31, 2024 | -64.10 Mn |